EA200700532A1 - Очищенная композиция арабиногалактан-белка (agp) - Google Patents

Очищенная композиция арабиногалактан-белка (agp)

Info

Publication number
EA200700532A1
EA200700532A1 EA200700532A EA200700532A EA200700532A1 EA 200700532 A1 EA200700532 A1 EA 200700532A1 EA 200700532 A EA200700532 A EA 200700532A EA 200700532 A EA200700532 A EA 200700532A EA 200700532 A1 EA200700532 A1 EA 200700532A1
Authority
EA
Eurasian Patent Office
Prior art keywords
arabinogalactan
agp
protein
inhibition
purified composition
Prior art date
Application number
EA200700532A
Other languages
English (en)
Other versions
EA012208B1 (ru
Inventor
Судершан Кумар Арора
Вандита Сривастава
Самир Шанкар Валундж
Original Assignee
Люпин Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Люпин Лимитед filed Critical Люпин Лимитед
Publication of EA200700532A1 publication Critical patent/EA200700532A1/ru
Publication of EA012208B1 publication Critical patent/EA012208B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

Описана очищенная композиция арабиногалактан-белка (AGP), выделенная посредством селективного способа из листьев и/или стеблей растения Agremone mexicana. Описана также очищенная композиция арабиногалактан-белка (AGP), выделенная из листьев и/или стеблей растения Agremone mexicana, которая имеет одно или несколько из следующих действий: иммуносупрессию, ингибирование лимфопролиферации, модуляцию цитокинов, например, ингибирование IL-2, ингибирование IFN-γ или индукцию IL-10;ингибирование пролиферации кератиноцитов, кератолитическую активность и ингибирующую активность в тесте опухания уха мыши (MEST) .
EA200700532A 2004-09-01 2005-04-26 Очищенная композиция арабиногалактан-белка (agp) EA012208B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/931,814 US7601368B2 (en) 2004-09-01 2004-09-01 Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders
PCT/IN2005/000132 WO2006025068A1 (en) 2004-09-01 2005-04-26 A purified arabinogalactan-protein (agp) composition

Publications (2)

Publication Number Publication Date
EA200700532A1 true EA200700532A1 (ru) 2007-08-31
EA012208B1 EA012208B1 (ru) 2009-08-28

Family

ID=35943518

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700532A EA012208B1 (ru) 2004-09-01 2005-04-26 Очищенная композиция арабиногалактан-белка (agp)

Country Status (19)

Country Link
US (4) US7601368B2 (ru)
EP (1) EP1789439B1 (ru)
JP (1) JP2008511613A (ru)
KR (1) KR20070059062A (ru)
CN (1) CN101044161A (ru)
AP (1) AP2007003929A0 (ru)
AT (1) ATE452142T1 (ru)
AU (1) AU2005278780A1 (ru)
BR (1) BRPI0514347A (ru)
CA (1) CA2577134A1 (ru)
DE (1) DE602005018375D1 (ru)
EA (1) EA012208B1 (ru)
IL (1) IL181230A0 (ru)
MX (1) MX2007002428A (ru)
NO (1) NO20071120L (ru)
TN (1) TNSN07079A1 (ru)
UA (1) UA86986C2 (ru)
WO (1) WO2006025068A1 (ru)
ZA (1) ZA200701311B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1964570T3 (da) 2007-03-02 2012-12-17 Protectimmun Gmbh Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme
FR2938192B1 (fr) 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
US20120128597A1 (en) * 2008-08-16 2012-05-24 Forschungszentrum Borstel Composition for prevention and treatment of allergic and/or inflammatory diseases
EP2566485B1 (en) * 2010-05-05 2017-04-12 Comvita New Zealand Limited Immunostimulatory compositions and methods of use thereof
FR2975004B1 (fr) * 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
ITMI20112216A1 (it) 2011-12-05 2013-06-06 Fond Salvatore Maugeri Clinic A Del Lavoro E Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee
WO2014190398A1 (en) * 2013-05-31 2014-12-04 The University Of Melbourne Inhibition of amyloid fibril formation
WO2017093276A1 (en) 2015-12-01 2017-06-08 Protectimmun Gmbh Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
EP3176175B1 (en) 2015-12-01 2020-07-01 Ruhr-Universität Bochum Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
JP6230638B2 (ja) * 2016-02-12 2017-11-15 株式会社らいむ 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液
CN108603115A (zh) 2016-02-12 2018-09-28 来姆有限公司 神经生长促进剂及其制造方法、内服剂、培养基用添加剂、细胞稀释液用添加剂、培养基、细胞稀释液、抗氧化剂及其制造方法、外用剂、以及伤口治疗剂及其制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
JP3177642B2 (ja) * 1991-09-10 2001-06-18 ライオン株式会社 抗男性ホルモン剤
WO2001000682A1 (en) 1999-06-30 2001-01-04 Pharmagenesis, Inc. Hematopoietic arabinogalactan composition
CA2471490A1 (en) * 2002-01-10 2003-07-17 Lupin Limited Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders

Also Published As

Publication number Publication date
UA86986C2 (ru) 2009-06-10
CA2577134A1 (en) 2006-03-09
WO2006025068A8 (en) 2006-04-20
NO20071120L (no) 2007-05-14
CN101044161A (zh) 2007-09-26
US20090270330A1 (en) 2009-10-29
BRPI0514347A (pt) 2008-06-10
US20060045930A1 (en) 2006-03-02
TNSN07079A1 (en) 2008-06-02
ATE452142T1 (de) 2010-01-15
EP1789439A1 (en) 2007-05-30
US20100330650A1 (en) 2010-12-30
KR20070059062A (ko) 2007-06-11
MX2007002428A (es) 2007-05-11
ZA200701311B (en) 2009-08-26
AU2005278780A1 (en) 2006-03-09
WO2006025068A1 (en) 2006-03-09
EP1789439B1 (en) 2009-12-16
US20090264341A1 (en) 2009-10-22
IL181230A0 (en) 2007-07-04
EA012208B1 (ru) 2009-08-28
DE602005018375D1 (de) 2010-01-28
US7601368B2 (en) 2009-10-13
AP2007003929A0 (en) 2007-02-28
JP2008511613A (ja) 2008-04-17

Similar Documents

Publication Publication Date Title
EA200700532A1 (ru) Очищенная композиция арабиногалактан-белка (agp)
BR0307432B1 (pt) difluormetiltiazolilcarboxanilidas
RS115004A (en) Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof
MY142777A (en) Substituted indole-o-glucosides
UA87991C2 (en) Substituted indole-o-glucosides
NO20013003L (no) Kinolin-derivater
WO2003084922A8 (de) Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
SG149061A1 (en) Definitive endoderm
DK1309592T3 (da) Substituerede pyrazoler
CY1107319T1 (el) Μεθοδος για τον καθαρισμο βακτηριακων κυτταρων και κυτταρικων συστατικων
DE50310579D1 (de) Furancarboxamide
UY25113A1 (es) Composiciones parenterales de alatrofloxacino
DE60119110D1 (de) Verfahren zum quellen
WO2002001951A3 (en) Optically pure(-) clethodim, compositions and methods for controlling plant growth comprising the same
AU2003232775A1 (en) Oxathiincarboxamides
GB2441600A (en) A purified arabinogalactan-protein (AGP) composition.
DE50303586D1 (de) Methylthiophencarboxanilide
PL1664307T3 (pl) Nowy, specyficzny dla bielma promotor roślinny dla roślin uprawnych
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
WO2004113573A3 (en) Methods and compositions for analysis of plant gene function
ATE273293T1 (de) Aminoalkenylbenzoyl-benzofurane oder benzothiophene, verfahren zur ihrer herstellung und sie enthaltende zubereitungen
WO2002004010A3 (en) Inhibition of tumor growth by a nematode anticoagulant protein
MX9804048A (es) Ciclopeptolidos.
WO2002094836A3 (en) Methods for preparation and use of psorospermin analogs

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU